Risperidone ISM as a New Option in the Clinical Management of Schizophrenia: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s12325-022-02299-8
Published Online: 2022-09-01
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Álamo, Cecilio http://orcid.org/0000-0001-7652-7931
Funding for this research was provided by:
Rovi
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
Received: 12 May 2022
Accepted: 8 August 2022
First Online: 1 September 2022